Scientists identify mutant enzyme that helps prostate cancer spread and become more aggressive

Scientists have identified how a specific enzyme plays a key role in enabling prostate cancer to become more aggressive and harder to treat. A team at Nottingham Trent University has found that “transglutaminase 2” (TG2) which is abundant in many of the body’s cells, is responsible for driving a process which leads to the progression and spreading of prostate cancer. […]

» Read more

Pro-inflammatory diet linked to worsening relapse rate in MS

For people with multiple sclerosis (MS), a pro-inflammatory diet is associated with worsening relapse rate and greater periventricular fluid-attenuated inversion recovery lesion volume, according to a study published online May 6 in Multiple Sclerosis Journal. Alice M. Saul, from the University of Tasmania in Australia, and colleagues examined whether Dietary Inflammatory Index (DII) scores correlate with measures of MS progression […]

» Read more

Canadian Experts Call for Collecting Race and Ethnicity Data

A new commentary encourages the collection of information on race and Indigenous identity across Canada during health card renewal to help address inequities in health care. The statement suggests that the data could be beneficial for reducing racial disparities if used thoughtfully. However, the authors also advise caution and lay out several important considerations, including maintaining data governance and engagement […]

» Read more

New hope for cystic fibrosis patients as groundbreaking treatment enters clinical trial

Clinical testing is underway for a potentially groundbreaking new treatment for cystic fibrosis. Pioneered by scientists at Carle Illinois College of Medicine at the University of Illinois Urbana-Champaign and the Carver College of Medicine at the University of Iowa in partnership with the spin-out biotechnology company, cystetic Medicines, this promising inhalable molecular prosthetic is intended to improve lung function in […]

» Read more

Cis-regulatory sequences indicative of nasopharyngeal carcinoma risk identified

Research led by the Sun Yat-sen University Cancer Center in China has highlighted genetic risks for nasopharyngeal carcinoma. In a paper titled “High-throughput identification of regulatory elements and functional assays to uncover susceptibility genes for nasopharyngeal carcinoma” published in The American Journal of Human Genetics, the international team applied multiple genomic approaches in identifying genes critical to the development of […]

» Read more

Endometrial cancer risk and trends among distinct African-descent populations

Current evidence indicates Black women in the U.S. are at greater risk of developing advanced uterine cancer, also known as endometrial cancer, and of developing its more aggressive form—non-endometroid cancer—than white women. But research to date has mostly studied Black women as a homogenous group, and there is limited data about specific African-descent subpopulations worldwide. That is until now. A […]

» Read more

FDA Approves Suflave

FDA Approves Suflave (polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride) Colonoscopy Preparation that Tastes Similar to a Sports Drink BRAINTREE, Mass., June 22, 2023 /PRNewswire/ — Sebela Pharmaceuticals today announced that the U.S. Food and Drug Administration (FDA) granted approval of Suflave™ (polyethylene glycol, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral […]

» Read more

Microbiome: Certain gut microbes may warn of Alzheimers disease long before the first symptoms begin

What if the microbes in your gut could act as an early warning system, alerting you that you could be developing Alzheimer’s disease? This might sound improbable, but recent research has found certain microbes are more common in those with very early signs of the disease, pointing to a potential new method of diagnosis for a disease that affects millions […]

» Read more
1 109 110 111 112 113 1,330